Alison Lap‐tak

676 total citations
36 papers, 323 citations indexed

About

Alison Lap‐tak is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Alison Lap‐tak has authored 36 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Nephrology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Rheumatology. Recurrent topics in Alison Lap‐tak's work include Renal Diseases and Glomerulopathies (15 papers), Systemic Lupus Erythematosus Research (9 papers) and Dialysis and Renal Disease Management (5 papers). Alison Lap‐tak is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Systemic Lupus Erythematosus Research (9 papers) and Dialysis and Renal Disease Management (5 papers). Alison Lap‐tak collaborates with scholars based in China, Hong Kong and United Kingdom. Alison Lap‐tak's co-authors include Eugene Yu-hin Chan, Kjell Tullus, Tak Mao Chan, Wai-ming Lai, Wilfred Hing Sang Wong, Daljit K. Hothi, Francis Calder, Rulan S. Parekh, Rukshana Shroff and Lesley Rees and has published in prestigious journals such as Kidney International, The Journal of Pediatrics and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Alison Lap‐tak

31 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Lap‐tak China 10 220 119 73 41 41 36 323
Diana Carretero Spain 7 287 1.3× 15 0.1× 70 1.0× 17 0.4× 42 1.0× 8 428
Isabel Roberti United States 10 98 0.4× 28 0.2× 61 0.8× 15 0.4× 6 0.1× 22 306
Tanja Kersnik Levart Slovenia 11 124 0.6× 31 0.3× 72 1.0× 27 0.7× 3 0.1× 29 329
Bernardo Faria Portugal 10 194 0.9× 16 0.1× 124 1.7× 17 0.4× 54 1.3× 23 442
Roger Sinclair Australia 6 157 0.7× 31 0.3× 111 1.5× 10 0.2× 6 0.1× 8 355
S C Dash India 9 151 0.7× 34 0.3× 56 0.8× 40 1.0× 2 0.0× 25 279
Ewa Wątorek Poland 12 89 0.4× 11 0.1× 144 2.0× 11 0.3× 120 2.9× 28 382
Y. Tanter France 11 79 0.4× 27 0.2× 87 1.2× 15 0.4× 3 0.1× 31 283
Hojong Park South Korea 10 47 0.2× 17 0.1× 153 2.1× 17 0.4× 31 0.8× 27 273
A Caralps Spain 12 89 0.4× 21 0.2× 159 2.2× 7 0.2× 10 0.2× 57 340

Countries citing papers authored by Alison Lap‐tak

Since Specialization
Citations

This map shows the geographic impact of Alison Lap‐tak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Lap‐tak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Lap‐tak more than expected).

Fields of papers citing papers by Alison Lap‐tak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Lap‐tak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Lap‐tak. The network helps show where Alison Lap‐tak may publish in the future.

Co-authorship network of co-authors of Alison Lap‐tak

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Lap‐tak. A scholar is included among the top collaborators of Alison Lap‐tak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Lap‐tak. Alison Lap‐tak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fung, Kenneth, et al.. (2025). Acquired cystic kidney disease in children with kidney failure. Pediatric Nephrology. 40(5). 1741–1750. 1 indexed citations
2.
Lap‐tak, Alison, et al.. (2025). Long‐Term Clinical Outcomes of Paediatric Kidney Transplantation in Hong Kong—A Territory‐Wide Study. Nephrology. 30(3). e70009–e70009. 1 indexed citations
3.
Chan, Eugene Yu-hin, et al.. (2024). Renal vascular lesions in childhood-onset lupus nephritis. Pediatric Nephrology. 40(1). 131–141. 1 indexed citations
4.
Chan, Eugene Yu-hin, Wilfred Hing Sang Wong, Jennifer Li, et al.. (2023). Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study. Lara D. Veeken. 63(4). 953–961. 14 indexed citations
5.
Chan, Eugene Yu-hin, et al.. (2023). Managing Lupus Nephritis in Children and Adolescents. Pediatric Drugs. 26(2). 145–161. 12 indexed citations
6.
Chan, Eugene Yu-hin, et al.. (2023). Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review. Pediatric Nephrology. 39(1). 85–103. 6 indexed citations
7.
Chan, Eugene Yu-hin, et al.. (2023). Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis. Pediatric Nephrology. 38(12). 4001–4011. 15 indexed citations
8.
Lap‐tak, Alison, Daniel Leung, Eugene Yu-hin Chan, et al.. (2022). Antibody responses to 2 doses of mRNA COVID-19 vaccine in pediatric patients with kidney diseases. Kidney International. 101(5). 1069–1072. 9 indexed citations
9.
Chan, Eugene Yu-hin, et al.. (2022). Long-Term Outcomes of Children and Adolescents With Biopsy-Proven Childhood-Onset Lupus Nephritis. Kidney International Reports. 8(1). 141–150. 27 indexed citations
10.
Chan, Eugene Yu-hin, et al.. (2022). Outcomes and perception of cloud-based remote patient monitoring in children receiving automated peritoneal dialysis: a prospective study. Pediatric Nephrology. 38(7). 2171–2178. 6 indexed citations
11.
Chan, Eugene Yu-hin, et al.. (2022). Embolisation of an aneurysmal high-flow renal arteriovenous fistula in a paediatric patient: simultaneous arterial and venous approach. CVIR Endovascular. 5(1). 24–24. 3 indexed citations
12.
Chan, Eugene Yu-hin, et al.. (2021). Demographics and long‐term outcomes of children with end‐stage kidney disease: A 20‐year territory‐wide study. Nephrology. 27(2). 171–180. 15 indexed citations
13.
Chan, Eugene Yu-hin, et al.. (2020). Left ventricular stiffness in paediatric patients with end-stage kidney disease. Pediatric Nephrology. 35(6). 1051–1060. 8 indexed citations
14.
Chan, Eugene Yu-hin, Alison Lap‐tak, & Kjell Tullus. (2020). When should we start and stop ACEi/ARB in paediatric chronic kidney disease?. Pediatric Nephrology. 36(7). 1751–1764. 17 indexed citations
15.
Chan, Eugene Yu-hin, Hazel Webb, E. Yu, et al.. (2019). Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney International. 97(2). 393–401. 66 indexed citations
17.
Lap‐tak, Alison, Rukshana Shroff, & Stephen D. Marks. (2016). An unusual case of renal failure: Questions. Pediatric Nephrology. 32(1). 77–78.
18.
Chan, Eugene Yu-hin, et al.. (2016). Chronic peritoneal dialysis in Chinese infants and children younger than two years. Hong Kong Medical Journal. 22(4). 365–71. 6 indexed citations
19.
Lap‐tak, Alison, et al.. (2016). Measuring Erythrocyte Thiopurine Methyltransferase Activity in Children—Is It Helpful?. The Journal of Pediatrics. 179. 216–218. 1 indexed citations
20.
Lap‐tak, Alison, et al.. (2012). A girl with difficult lupus nephritis: lupus vasculopathy. Clinical and Experimental Nephrology. 16(6). 968–972. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026